Blue Matter is a Gold Sponsor of BioFuture, Oct. 27-28, 2026 in New York City.
Blue Matter Partner, Tara Austraat-Churik will participate in the following panel discussion on Wednesday, Oct. 28 (2:00 pm – 2:55 pm):
“Big Think” Plenary Session > AI & Deep Tech: Refining Health Innovation – Drug Discovery, Diagnostics and Delivery
Artificial intelligence and deep tech in drug discovery have successfully compressed preclinical timelines from years to months and boosted Phase I safety success rates, but they have not yet fundamentally solved the overarching 85% to 90% clinical failure rate in human efficacy trials – yet.
Moderator:
Beth Rogozinski, CEO, Oncoustics
Panelists:
- Tara Austraat-Churik, Partner, Blue Matter
- Karen Akinsanya, President, R&D – Therapeutics & Chief Strategy Officer, Partnering, Schrödinger
- Ingrid Müller, COO, Evotec
- Additional panelist TBA
